HR 4007
PHARA Act of 2025
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The PHARA Act of 2025 aims to ensure that funding for existing National Institutes of Health (NIH) grants remains available and is fully utilized. It prohibits the termination of these grants, particularly those involving active research, and requires new grant agreements to include specific termination clauses. The bill also prevents NIH from terminating grants simply because they no longer align with the agency’s priorities.
Key provisions
- Releases and expends all available funding for existing NIH grant agreements.
- Prohibits termination of grants involving active and ongoing research.
- Requires new NIH grant agreements to include termination clauses with a 90-day notice requirement.
- Prevents NIH from terminating grants based solely on a change in program goals or agency priorities.
- Directs the NIH to revise regulations to align with the bill’s provisions.
Who is affected
- National Institutes of Health (NIH)
- Researchers receiving NIH grants
- Federal agencies
- Grant recipients
- The Department of Health and Human Services
Notable changes
- Requires new grant agreements to include termination clauses.
- Prohibits termination of grants with active research.
- Establishes a 90-day notice period for grant termination.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 1st Session
H. R. 4007
IN THE HOUSE OF REPRESENTATIVES
A BILL
To unfreeze and release funding for grant agreements of the National Institutes of Health, prohibit termination of such agreements for active and ongoing research, require the inclusion of termination clauses in such agreements, and prohibit termination of such agreements for no longer effectuating program goals or agency priorities.
This Act may be cited as the Prevent Halting of Active Research Act of 2025 PHARA Act of 2025
or the
.
The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (in this section referred to as the Secretary
)—
shall, immediately after the date of the enactment of this Act, with respect to a grant agreement or cooperative agreement entered into by the Secretary—
release and expend all funding to the extent required by such agreement; and
otherwise fully implement such agreement;
may not cancel any agreement described in paragraph (1) under which an awardee is performing active and ongoing research.
Any grant agreement or cooperative agreement from the National Institutes of Health that is entered into after the date of the enactment of this Act shall include a termination clause. Such clause shall specify that the agreement may only be terminated in cases of material breach, change in circumstances, or mutual agreement of all parties, provided that—
the terminating party invoking such clause submits to all non-terminating parties a written notice of the intent to terminate at least 90 days before the date of termination; and
before the date of termination, the terminating party attempts to amend the terms of the grant agreement or cooperative agreement with each non-terminating party.